Skip to content

Vertex Pharmaceuticals reports 7.1% stake in Kymera

September 3, 2020

Vertex Pharmaceuticals (NASDAQ:VRTX) acquires ~3.15M shares of Kymera Therapeutics (NASDAQ:KYMR), representing 7.1% of its total shares outstanding.

Shares were acquired pursuant to Vertex’s collaboration with Kymera and in a private placement that was closed concurrently with the closing of Kymera’s IPO on August 25, 2020.

Vertex had paid an initial consideration of $70M, including $50M upfront payment and $20M worth equity investment.

Press Release

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: